Doosan Fuel Cell (A336260) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
24 Jun, 2026Executive summary
Q2 2025 sales rose 48.5% year-over-year and 28.8% quarter-over-quarter, reaching KRW 128.5bn, driven by increased product deliveries.
Specializes in fuel cell technology for power generation, with H1 2025 revenue of KRW 228.2bn and operating loss of KRW 13.5bn.
Main business: supply of fuel cell equipment (71% of 2024 sales) and long-term maintenance services (29%).
Holds 49% cumulative market share in Korea’s power fuel cell market.
Expanded into eco-friendly commercial vehicles via 100% acquisition of HyAxiom Motors in January 2024.
Financial highlights
Q2 2025 consolidated sales: KRW 128.5bn; operating loss: KRW 1.9bn.
H1 2025 consolidated revenue: KRW 228.2bn, down from KRW 411.8bn in FY2024.
Gross profit for Q2 2025 was KRW 8.9bn, with EBITDA at KRW 3.1bn.
Net loss narrowed to KRW 2.6bn in Q2 2025 from KRW 10.1bn in Q1; H1 2025 net loss attributable to owners: KRW 12.7bn.
Cash and cash equivalents: KRW 59.4bn at June 2025, down from KRW 137.6bn at end-2024.
Outlook and guidance
Significant order growth is expected in 2025, with 127MW of CHPS projects to be reflected in orders and new overseas opportunities being pursued.
Sales are projected to double within five years if a 50% market share in CHPS bidding is achieved.
Product deliveries in H2 2025 are expected to exceed KRW 300bn.
Mid- to long-term sales CAGR forecasted at +15%.
Anticipates continued growth in hydrogen and fuel cell markets, driven by government policy and clean energy mandates.
Latest events from Doosan Fuel Cell
- Sales jumped 173% QoQ in 2Q24, with new H2 models and SOFC investments boosting outlook.A336260
Q2 202424 Jun 2026 - Revenue fell sharply with a net loss, but CHPS orders and SOFC growth support a rebound.A336260
Q3 202424 Jun 2026 - Q1 2025 sales tripled YoY to KRW 99.8B, but losses widened amid ongoing expansion.A336260
Q1 202524 Jun 2026 - Q3 2025 saw KRW 319B revenue, operating loss, and strong order growth expected.A336260
Q3 202524 Jun 2026 - Q1 2026 revenue up 45% YoY, operating loss narrows, and EBITDA turns positive.A336260
Q1 202629 Apr 2026 - 2025 saw sales growth but deeper losses, with strong sales and order growth expected from 2026.A336260
Q4 202516 Mar 2026 - Sales up 58% YoY, CHPS market share at 73%, net loss due to higher costs, strong 2025 outlook.A336260
Q4 202420 Feb 2026